Drugs / CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE
CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00458679 | Dec 2006 → Oct 2008 | B-cell chronic lymphocytic leukemia | Baylor College of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD40 LIGAND AND IL-2-EXPRESSING TUMOR CELLS VACCINE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00458679 ↗ |
| Modality | Vaccine | “act like a vaccine” NCT00458679 ↗ |
| Route | Subcutaneous | “the modified cancer cells will be injected under the skin” NCT00458679 ↗ |